Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Proteomics to Predict Loss of RXR-γ During Progression of Epithelial Ovarian Cancer.

Kalra RS, Bapat SA.

Methods Mol Biol. 2019;2019:1-14. doi: 10.1007/978-1-4939-9585-1_1.

PMID:
31359385
2.

Uncoupling Traditional Functionalities of Metastasis: The Parting of Ways with Real-Time Assays.

Varankar SS, Bapat SA.

J Clin Med. 2019 Jun 28;8(7). pii: E941. doi: 10.3390/jcm8070941. Review.

3.

Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines.

Varankar SS, More M, Abraham A, Pansare K, Kumar B, Narayanan NJ, Jolly MK, Mali AM, Bapat SA.

Carcinogenesis. 2019 Jun 25. pii: bgz119. doi: 10.1093/carcin/bgz119. [Epub ahead of print]

PMID:
31241128
4.

Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers.

Kamble SC, Sen A, Dhake RD, Joshi AN, Midha D, Bapat SA.

J Clin Med. 2019 Mar 8;8(3). pii: E330. doi: 10.3390/jcm8030330.

5.

Migratory Metrics of Wound Healing: A Quantification Approach for in vitro Scratch Assays.

Varankar SS, Bapat SA.

Front Oncol. 2018 Dec 18;8:633. doi: 10.3389/fonc.2018.00633. eCollection 2018.

6.

Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.

Jolly MK, Somarelli JA, Sheth M, Biddle A, Tripathi SC, Armstrong AJ, Hanash SM, Bapat SA, Rangarajan A, Levine H.

Pharmacol Ther. 2019 Feb;194:161-184. doi: 10.1016/j.pharmthera.2018.09.007. Epub 2018 Sep 28. Review.

PMID:
30268772
7.

Tumor deconstruction as a tool for advanced drug screening and repositioning.

Naik RR, Luo T, Kohandel M, Bapat SA.

Pharmacol Res. 2016 Sep;111:815-819. doi: 10.1016/j.phrs.2016.07.018. Epub 2016 Jul 16.

PMID:
27431330
8.
9.

Derivation of a fifteen gene prognostic panel for six cancers.

Khirade MF, Lal G, Bapat SA.

Sci Rep. 2015 Aug 14;5:13248. doi: 10.1038/srep13248.

10.

Auto-regulation of Slug mediates its activity during epithelial to mesenchymal transition.

Kumar B, Uppuladinne MV, Jani V, Sonavane U, Joshi RR, Bapat SA.

Biochim Biophys Acta. 2015 Sep;1849(9):1209-18. doi: 10.1016/j.bbagrm.2015.07.006. Epub 2015 Jul 11.

11.

Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.

Singh AK, Chandra N, Bapat SA.

Clin Cancer Res. 2015 Nov 15;21(22):5151-63. doi: 10.1158/1078-0432.CCR-15-0505. Epub 2015 Jun 30.

12.

A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses.

Naik RR, Singh AK, Mali AM, Khirade MF, Bapat SA.

Oncogene. 2016 Feb 11;35(6):727-37. doi: 10.1038/onc.2015.130. Epub 2015 Apr 27.

PMID:
25915841
13.

Discrete molecular classes of ovarian cancer suggestive of unique mechanisms of transformation and metastases.

Gardi NL, Deshpande TU, Kamble SC, Budhe SR, Bapat SA.

Clin Cancer Res. 2014 Jan 1;20(1):87-99. doi: 10.1158/1078-0432.CCR-13-2063. Epub 2013 Oct 16.

14.
15.

Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer.

Kalra RS, Bapat SA.

PLoS One. 2013 Aug 6;8(8):e70398. doi: 10.1371/journal.pone.0070398. Print 2013.

16.

Epigenetic regulation of cancer stem cell gene expression.

Bapat SA.

Subcell Biochem. 2013;61:419-34. doi: 10.1007/978-94-007-4525-4_18. Review.

PMID:
23150261
17.

Spectrum of CREBBP mutations in Indian patients with Rubinstein-Taybi syndrome.

Sharma N, Mali AM, Bapat SA.

J Biosci. 2010 Jun;35(2):187-202.

18.

Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.

Bapat SA, Jin V, Berry N, Balch C, Sharma N, Kurrey N, Zhang S, Fang F, Lan X, Li M, Kennedy B, Bigsby RM, Huang TH, Nephew KP.

Epigenetics. 2010 Nov-Dec;5(8):716-29. Epub 2010 Nov 1.

19.

Gene expression: protein interaction systems network modeling identifies transformation-associated molecules and pathways in ovarian cancer.

Bapat SA, Krishnan A, Ghanate AD, Kusumbe AP, Kalra RS.

Cancer Res. 2010 Jun 15;70(12):4809-19. doi: 10.1158/0008-5472.CAN-10-0447. Epub 2010 Jun 8.

20.

Human ovarian cancer stem cells.

Bapat SA.

Reproduction. 2010 Jul;140(1):33-41. doi: 10.1530/REP-09-0389. Epub 2010 Mar 16. Review.

PMID:
20368192
21.

CREBBP re-arrangements affect protein function and lead to aberrant neuronal differentiation.

Sharma N, Jadhav SP, Bapat SA.

Differentiation. 2010 Apr-Jun;79(4-5):218-31. doi: 10.1016/j.diff.2010.02.001. Epub 2010 Mar 6.

PMID:
20207472
22.

Modulation of gene expression in ovarian cancer by active and repressive histone marks.

Bapat SA.

Epigenomics. 2010 Feb;2(1):39-51. doi: 10.2217/epi.09.38. Review.

PMID:
22122747
23.

Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy.

Kusumbe AP, Bapat SA.

Cancer Res. 2009 Dec 15;69(24):9245-53. doi: 10.1158/0008-5472.CAN-09-2802.

24.

Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells.

Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, Bapat SA.

Stem Cells. 2009 Sep;27(9):2059-68. doi: 10.1002/stem.154.

25.

CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature.

Kusumbe AP, Mali AM, Bapat SA.

Stem Cells. 2009 Mar;27(3):498-508. doi: 10.1634/stemcells.2008-0868.

26.

Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype.

Berry NB, Bapat SA.

J Ovarian Res. 2008 Nov 24;1:8. doi: 10.1186/1757-2215-1-8.

27.

Analysis of reactive oxygen species and antioxidant defenses in complex I deficient patients revealed a specific increase in superoxide dismutase activity.

Wani AA, Rangrez AY, Kumar H, Bapat SA, Suresh CG, Barnabas S, Patole MS, Shouche YS.

Free Radic Res. 2008 May;42(5):415-27.

PMID:
18551809
28.

Analysis of mitochondrial DNA sequences in childhood encephalomyopathies reveals new disease-associated variants.

Wani AA, Ahanger SH, Bapat SA, Rangrez AY, Hingankar N, Suresh CG, Barnabas S, Patole MS, Shouche YS.

PLoS One. 2007 Sep 26;2(9):e942.

29.

Epigenetic "bivalently marked" process of cancer stem cell-driven tumorigenesis.

Balch C, Nephew KP, Huang TH, Bapat SA.

Bioessays. 2007 Sep;29(9):842-5.

PMID:
17688287
30.

Evolution of cancer stem cells.

Bapat SA.

Semin Cancer Biol. 2007 Jun;17(3):204-13. Epub 2006 May 20. Review.

PMID:
16787749
31.

Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells.

Wani AA, Sharma N, Shouche YS, Bapat SA.

Oncogene. 2006 Oct 12;25(47):6336-44. Epub 2006 May 29.

PMID:
16732329
32.

Stem cell pharmacogenomics: a reality check on stem cell therapy.

Bapat SA, Mishra GC.

Curr Opin Mol Ther. 2005 Dec;7(6):551-6. Review.

PMID:
16370378
33.

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer.

Bapat SA, Mali AM, Koppikar CB, Kurrey NK.

Cancer Res. 2005 Apr 15;65(8):3025-9.

34.

Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level.

Kurrey NK, K A, Bapat SA.

Gynecol Oncol. 2005 Apr;97(1):155-65.

PMID:
15790452
35.

Stem cell pharmacogenomics.

Bapat SA, Mishra GC.

Curr Top Med Chem. 2004;4(13):1371-83. Review.

PMID:
15379651
36.

Higher offspring birth weight predicts the metabolic syndrome in mothers but not fathers 8 years after delivery: the Pune Children's Study.

Yajnik CS, Joglekar CV, Pandit AN, Bavdekar AR, Bapat SA, Bhave SA, Leary SD, Fall CH.

Diabetes. 2003 Aug;52(8):2090-6.

37.

Occurrence and frequency of precocious germination of somatic embryos is a genotpye - dependent phenomenon in wheat.

Bapat SA, Joshi CP, Mascarenhas AF.

Plant Cell Rep. 1988 Dec;7(7):538-41. doi: 10.1007/BF00272751.

PMID:
24240411

Supplemental Content

Loading ...
Support Center